bf/NASDAQ:MDXG_icon.jpeg

COM:MIMEDX

MIMEDX

  • Stock

Last Close

9.22

22/11 21:00

Market Cap

1.35B

Beta: -

Volume Today

875.76K

Avg: -

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for ext...Show More

peer of

competitor of